Bourachot Brigitte, Yaniv Moshe, Muchardt Christian
Expression Génétique et Maladies, URA1644 du CNRS, Département de Biologie du Développement, Institut Pasteur, Paris, France.
EMBO J. 2003 Dec 15;22(24):6505-15. doi: 10.1093/emboj/cdg621.
In mammalian cells, the SWI-SNF chromatin-remodeling complex is a regulator of cell proliferation, and overexpression of the catalytic subunit Brm interferes with cell cycle progression. Here, we show that treatment with histone deacetylase (HDAC) inhibitors reduces the inhibitory effect of Brm on the growth of mouse fibroblasts. This observation led to the identification of two carboxy-terminal acetylation sites in the Brm protein. Mutation of these sites into non-acetylatable sequences increased both the growth-inhibitory and the transcriptional activities of Brm. We also show that culture in the presence of HDAC inhibitors facilitates the isolation of clones overexpressing Brm. Removal of the HDAC inhibitors from the growth medium of these clones leads to downregulation of cyclin D1. This downregulation is absent in cell transformed by oncogenic ras.
在哺乳动物细胞中,SWI-SNF染色质重塑复合体是细胞增殖的调节因子,催化亚基Brm的过表达会干扰细胞周期进程。在此,我们表明,用组蛋白去乙酰化酶(HDAC)抑制剂处理可降低Brm对小鼠成纤维细胞生长的抑制作用。这一观察结果导致在Brm蛋白中鉴定出两个羧基末端乙酰化位点。将这些位点突变为不可乙酰化序列会增加Brm的生长抑制活性和转录活性。我们还表明,在HDAC抑制剂存在的情况下培养有助于分离过表达Brm的克隆。从这些克隆的生长培养基中去除HDAC抑制剂会导致细胞周期蛋白D1的下调。在由致癌性ras转化的细胞中不存在这种下调。